127 related articles for article (PubMed ID: 25935484)
1. Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy.
Choi SH; Nam JK; Jang J; Lee HJ; Lee YJ
Biochem Biophys Res Commun; 2015 Jun; 462(2):138-43. PubMed ID: 25935484
[TBL] [Abstract][Full Text] [Related]
2. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
[TBL] [Abstract][Full Text] [Related]
3. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
4. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
Schueneman AJ; Himmelfarb E; Geng L; Tan J; Donnelly E; Mendel D; McMahon G; Hallahan DE
Cancer Res; 2003 Jul; 63(14):4009-16. PubMed ID: 12873999
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib effects on the radiation response of endothelial and breast tumor cells.
El Kaffas A; Al-Mahrouki A; Tran WT; Giles A; Czarnota GJ
Microvasc Res; 2014 Mar; 92():1-9. PubMed ID: 24215790
[TBL] [Abstract][Full Text] [Related]
7. Effect of sunitinib combined with ionizing radiation on endothelial cells.
Zhang HP; Takayama K; Su B; Jiao XD; Li R; Wang JJ
J Radiat Res; 2011; 52(1):1-8. PubMed ID: 21187670
[TBL] [Abstract][Full Text] [Related]
8. Combination of human plasminogen kringle 5 with ionizing radiation significantly enhances the efficacy of antitumor effect.
Jin GH; Ma DY; Wu N; Marikar FM; Jin SZ; Jiang WW; Liu Y; Hua ZC
Int J Cancer; 2007 Dec; 121(11):2539-46. PubMed ID: 17680563
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.
Sonpavde G; Jian W; Liu H; Wu MF; Shen SS; Lerner SP
Urol Oncol; 2009; 27(4):391-9. PubMed ID: 18534874
[TBL] [Abstract][Full Text] [Related]
12. [Effect of irradiation on matrix metalloproteinases, vascular endothelial growth factor and microvessel density of mice bearing Lewis lung cancer].
Ai P; Ren ZG; Wang X; Wang SC; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):632-5. PubMed ID: 19764560
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice.
Rovida A; Castiglioni V; Decio A; Scarlato V; Scanziani E; Giavazzi R; Cesca M
Mol Cancer Ther; 2013 Oct; 12(10):2237-47. PubMed ID: 23918831
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor radiosensitivity by a survivin dominant-negative mutant.
Yuan QZ; Wang CT; Mao YQ; Zhang P; Shi HS; Li ZY; Pan L; Yu DD; Leng F; Chen X; Ying W; Xu JH; Li W; Wu F; Wen Y; Ma TT; Wei YQ
Oncol Rep; 2010 Jan; 23(1):97-103. PubMed ID: 19956869
[TBL] [Abstract][Full Text] [Related]
15. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
16. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
Bischof M; Abdollahi A; Gong P; Stoffregen C; Lipson KE; Debus JU; Weber KJ; Huber PE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1220-32. PubMed ID: 15519795
[TBL] [Abstract][Full Text] [Related]
17. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
18. Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancer.
Liljegren A; Bergh J; Castany R
Breast; 2009 Aug; 18(4):259-62. PubMed ID: 19744626
[TBL] [Abstract][Full Text] [Related]
19. The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma.
D'Amico R; Lei L; Kennedy BC; Sisti J; Ebiana V; Crisman C; Christensen JG; Gil O; Rosenfeld SS; Canoll P; Bruce JN
Neurol Res; 2012 Apr; 34(3):252-61. PubMed ID: 22449730
[TBL] [Abstract][Full Text] [Related]
20. The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway.
Liu D; Cao G; Cen Y; Liu T; Peng W; Sun J; Li X; Zhou H
Int Immunopharmacol; 2013 Oct; 17(2):237-44. PubMed ID: 23791618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]